The SYNTAX Score II: a tool that should be used

Original title: Validation and Comparison of the Long-Term Prognostic Capability of SYNTAX Store-II Among 1528 Consecutive Patients Who Underwent Left Main Percutaneous Coronary Intervention. Reference: Bo Xu, et al. JACC Cardiovascular Intervention 2014;7:1128-37.

 

The SYNTAX angiography score is useful when deciding revascularization in multivessel, but with the addition of clinical variables in the second version, SYNTAX score has improved its performance in predicting mortality. 1528 consecutive patients who underwent angioplasty to left main coronary artery unprotected were analyzed. The primary endpoint was the ability of the SYNTAX score II to predict mortality. Patients were divided into 3 tertiles: ≤21 points with 508 patients, >21 and ≤28 points with 480 patients and >28 points with 540 patients. Those in the highest tertile had higher age, more women, more history of heart attack and stroke, lower ejection fraction, creatinine clearance, and greater coronary disease with more complex lesions and presence of 2 or 3 vessels. At follow-up to four years, the rate of death, cardiac death, myocardial infarction and target vessel revascularization was respectively 4.4%, 5%, 7.5% and 9.5%, being significantly higher in the highest and intermediate tertile. In the multivariate, the SYNTAX Score II was predictor of mortality (HR: 1.76, 95% IC: 1.1 to 2.82 p = 0.02) in patients receiving angioplasty in the unprotected left main coronary artery (ULMCA). Besides the classic SYNTAX angiographic score and SYNTAX score II were compared giving the latter a better prediction of long-term mortality and a 25% index of reclassifying patients.

Conclusion

The results of this important series of consecutive patients who underwent angioplasty to unprotected left main coronary artery suggests that the SYNTAX score II has greater power to predict mortality compared with classic SYNTAX angiographic score.

Comment

The SYNTAX score II is helpful because it combines clinical with anatomy predicting late mortality. This tool should be used in all patients when deciding revascularization strategy. It will be necessary to set randomized studies comparing surgery with angioplasty combining the different SYNTAX Scores (SS residual, Syntax revascularization index, Syntax Delta Score) along with second-generation DES plus FFR and endovascular diagnostic imaging methods (IVUS or OCT) to evaluate these strategies in the current era. 

Courtesy Dr. Carlos Fava
Interventional cardiologist
Favaloro Foundation
Buenos Aires – Argentina

Carlos Fava

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...